AcneVulgaris Treatment Market, By Product Type (Medications and Devices) and byGeography – Global Industry Insights, Trends, Outlook, and OpportunityAnalysis, 2018-2026
Acne vulgaris is a common skindisease characterized by blackheads, whiteheads, papules, and pustules on theface, neck, back, and chest. It is commonly observed in adolescent population,however, can also affect adults. Depending on its severity, acne may besegmented into mild, moderate or severe. It is caused due to excess oilproduced in sebaceous glands under skin, which becomes plugged and inflated.Female patient with polycystic ovarian syndrome and even hormonal disorderssuch as excess androgen production may suffer from acne as well. People withacne vulgaris are usually characterized by social withdrawal, low self-esteem,and depression with suicidal tendencies.
U.S. is expected to be thelargest market for acne vulgaris treatment products over the forecast period
According to a study published inthe British Journal of Dermatology in 2015, 9.4% of global population wasestimated to be affected by acne. Moreover, globally, acne is the eight mostprevalent disease. The U.S. is the largest market for acne vulgaris treatmentproducts. According to study by National Institute of Health (NIH), in 2013,over US$ 3 Billion was spent for treating acne vulgaris in the U.S. In 2014,according to American Academy of Dermatology, the number of acne vulgarispatient aged 25 years and above, especially women, is risingsignificantly. Furthermore, lowawareness regarding the factors causing acne is another factor leading toincreasing prevalence acne vulgaris.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1260
Treatment for acne on an averagelasts for two years, therefore companies capitalize on this and earnsustainable revenue from acne treatment products. Majority of the populationsuffering from acne prefer OTC products as first line therapy. However, somehave to visit dermatologist to cure acne vulgaris on account of ineffectiveresult from OTC products.
India is expected to have largestpool of population in the age group 15–25 years by 2020. This, in turn, makesit a highly lucrative market for acne vulgaris treatment products. India alsohas high glycemic index diet, which is further expected to aid in growth of themarket over the forecast period. Manufacturers are also focusing on developingproducts for scarring, resulting from acne. New treatments such as cosmetic(laser, chemical peel, and photodynamic therapy) and surgical procedures arebeen developed for treatment of scarring. Increasing consumer inclinationtowards alternative way to treat acne vulgaris such as herbal therapy (tee treeoil), owing to low side effects is another factor expected to aid in growth ofthe acne vulgaris treatment market. Home-based devices for acne removal such asrevive light therapy and neutrogena light therapy are gaining significant tractionover the forecast period.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/acne-vulgaris-treatment-market-1260
Key players in the acne vulgaristreatment market are focusing on collaboration, acquisition, and new productdevelopment strategies in order to enhance their product offerings andsustaining their position in the market. For instance, in 2017, L’Oréal — aglobal beauty company — signed an agreement with Valeant PharmaceuticalsInternational, Inc. to acquire its skin care brands portfolio which includesanti-acne brand AcneFree at US$1.3 billion. Also, in November 2017 Novan Inc.,announced its plans to conduct phase three clinical trial for its new anti-acnemolecule. Novan has unique nitric oxide technology, Nitrici, through which atimed release of nitric oxide from chemical entity is possible. This isbeneficial as nitric oxide has natural ability to revitalize tissue, killinvading microorganisms, prevent clotting, regulate inflammation, and even aidin removing cancer cells. Moreover, in 2017, Valeant PharmaceuticalsInternational, Inc. signed an agreement with Haitong International ZhonghuaFinance Acquisition Fund I, L.P, to sell its Obagi Medical Products businessfor US$ 190 million in cash. Obagi Medical Products have high presence in acne treatmentproducts market.
Key players in the global acnevulgaris treatment market are Allergan plc, GlaxoSmithKline plc, ValeantPharmaceutical International Inc., F.Hoffmann-La Roche AG, Mylan, N.V., BayerAG, Janssen Pharma Inc., Galderma Inc., Pfizer Inc., and Novan Inc.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1260
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
